Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A2TSL71
Thu, 29.07.2021
SYNLAB AG
SYNLAB supports AXA Partners in enabling customers and employees to resume travel safely
SYNLAB and AXA Partners leverage SYNLAB's broad international laboratory network and medical expertise to provide safe and easy COVID-19 testing, ensuring delivery of PCR test results within 24 to 48 hours
SYNLAB, Europe's leading medical diagnostic services p [ … ]
Mon, 26.07.2021
SYNLAB AG
- Gruppo Tronchet's long-standing regional presence in the Emilia-Romagna region bolster's SYNLAB's market share and leading position in Italy
- Gruppo Tronchet's integrated service offering, including diagnostics, medical visits, physiotherapy and rehabilitation, as well as occupational medicine, complements and expands SYNLAB's expertise and [ … ]
Mon, 12.07.2021
SYNLAB AG
SYNLAB AG
Moosacher Straße 88
80809 Munich
Germany
Comprehensive PCR COVID-19 testing ensures safer return to school after summer holidays
Safe and successful return to classroom teaching after the summer holidays will be paramount for the education and social well-being of school children
Early and accurate detection of infections helps to pro [ … ]
Thu, 10.06.2021
SYNLAB AG
SYNLAB AG
Moosacher Straße 88
80809 Munich
Germany
SYNLAB to continue providing COVID-19 testing at UEFA competition matches and UEFA EURO 2020
SYNLAB appointed by UEFA as 'UEFA Laboratory Diagnostics Provider 2021/2022' to be responsible for COVID-19 testing for players, officials and venue staff, which is an essential part of UEFA's Retur [ … ]
Wed, 26.05.2021
SYNLAB AG
SYNLAB and Hospital District of Helsinki and Uusimaa extend partnership for comprehensive PCR-testing for SARS-CoV-2 in Finland
- SYNLAB and Hospital District of Helsinki and Uusimaa renew contract for comprehensive PCR-testing on SARS-CoV-2 in Finland
- SYNLAB will analyse and evaluate an estimated 5,000 - 20,000 PCR-tests per day, with SYNLAB' [ … ]
Wed, 12.05.2021
SYNLAB AG
SYNLAB delivers record growth in Q1 2021
- Nearly doubling revenue (+96%) in Q1'21 at EUR 938 million
- Strong SARS-CoV-2 testing volumes in Q1'21, above Q4'20
- Sustained underlying organic growth[1] at +3.7% supported by successful "For You" growth initiatives
- Adjusted EBITDA multiplied by 3.8x at EUR 324 million, margin showing strong volu [ … ]
Fri, 07.05.2021
SYNLAB AG
SYNLAB Holding Germany GmbH
Gubener Straße 39
86156 Augsburg
Press release
Highlights from SYNLAB Germany | SYNLAB supports the German state of North Rhine-Westphalia with regular lollipop-PCR-tests for pupils at elementary and specialist schools
For the state of North Rhine-Westphalia (NRW), SYNLAB will regularly test pupils for SARS-CoV-2 usi [ … ]
Mon, 03.05.2021
SYNLAB AG
SYNLAB Holding Germany GmbH
Gubener Strasse 39
86156 Augsburg
Press release
Highlights from SYNLAB Germany | Protection against COVID-19 at work: SYNLAB introduces new PCR pooling test method for companies
Growing infection rates and the continuous spread of coronavirus variants increase the need for testing where contact between people takes p [ … ]
Tue, 27.04.2021
Synlab AG
Total offer volume of EUR 772 million, assuming full exercise of Greenshoe option
Offer price implies a total market capitalisation of EUR 4 billion and a total enterprise value of EUR 5.9 billion
Free float expected to amount to 19% of outstanding share capital, if Greenshoe option is fully exercised
First day of trading on the Regulated Mar [ … ]